Upcoming Webinars
Are We There Yet? A Digital Maturity Model for Enabling Process Monitoring and Artificial Intelligence in Biologics Manufacturing
Presented by Jack Prior, Head of Process Monitoring & Data/AI Strategy at Sanofi, Masaki Yamada, Head of Product at Invert
16th September 2026
Future Path for E&L per ISO 10993‑18: A Look at Emerging Technical Specifications
Presented by Sandi Schaible, President and Founder of Bonded in Science, LLC, Kevin Rowland, M.S, Executive Vice President and General Manager at Jordi Labs
22nd September 2026
Analytical Assessment of Leachables in Biological Drug Products: FDA’s Approach to Reviewing Information and Representative Review Cases
Presented by Andrey Sarafanov, PhD., Principal Investigator at U.S. FDA, Center for Biologics Evaluation and Research, Sarah Brophy, Global Scientific Director, E&L Element Materials Technology
24th September 2026
Aseptic Manufacturing for mRNA, ADCs, and Novel Biologics
Presented by Francesco Cicirello, Senior Director, Global Quality Compliance – BioNTainer at BioNTech
29th September 2026
On Demand Webinars
From Error‑Prone Manual Steps to Flexible, Automated, Audit‑Ready Workflows: Delivering Better Results, Faster at genOway
Presented by Albane Flocon, Bioinformatics developer at genOway, Christel Merrouche, Head of preclinical processes at genOway and Stéphane Pitout - Director of Professional Sales (SciY)
02nd July 2026
Assessing the Use of Solid-Phase Cytometry for Rapid Bioburden Testing
Presented by Sophie Drinkwater, Associate Director in Microbiology at AstraZeneca
01st July 2026
Designed for More Than Launch: Accelerating Biosimilar Manufacturing at Scale
Presented by Mark Schofield, Cytiva, Director Science, Ingrid Long, Cytiva, Global Product Manager Bioprocess Downstream Hardware
22nd June 2026
Roundtable Discussion: Sterility Testing Challenges and Opportunities for ATMPs
Presented by Presented by Dr David Roesti, at Novartis Pharma AG, Irving Ford at Made Scientific, Dr Friedrich von Wintzingerode, at Roche-Genentech, Sophie Drinkwater, at AstraZeneca, Brian Conti, at Rapid Micro Biosystems, Dr. Joseph Pierquin, at Lonza and Stephane Dubreux at bioMérieux
27th May 2026

